Insiders · Profile

Kelly Jared

Chief Executive Officer at ONCOLYTICS BIOTECH. Filing since 11 Feb 2026. CIK 0002103581

Company

Date

Role

Action

Amount

Of holding

12 Mar 2026

Chief Executive Officer

Bought

5,050

$4.85K

4.6%

12 Feb 2026

Chief Executive Officer

Bought

29,500

$24.84K

37.1%

11 Feb 2026

Chief Executive Officer

Bought

5,600

$4.68K

7.6%

3 decisions on file.